MicroRNA dysregulation in diabetic ischemic heart failure patients
about
Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and PerspectivesInsulin resistance and hyperinsulinaemia in diabetic cardiomyopathyLooking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium SurvivalThe Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingNitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunctionExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Noncoding RNA in age-related cardiovascular diseasesCarbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathyDifferential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita heartsMicroRNAs as potential signatures of environmental exposure or effect: a systematic reviewMicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF SignalingIncreased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitusIdentification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseasesDeregulated microRNAs in myotonic dystrophy type 2Factors affecting the accuracy of a class prediction model in gene expression data.Diabetic cardiomyopathy: where we are and where we are going.HypoxamiR regulation and function in ischemic cardiovascular diseases.Circulating microRNAs and aerobic fitness--the HUNT-StudyThe SUR2B subunit of rat vascular KATP channel is targeted by miR-9a-3p induced by prolonged exposure to methylglyoxalSilencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.Copy number variations burden on miRNA genes reveals layers of complexities involved in the regulation of pathways and phenotypic expressionIdentifying module biomarker in type 2 diabetes mellitus by discriminative area of functional activity.miR-210: fine-tuning the hypoxic response.Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery.MicroRNAs and diabetic complicationsRoles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.Mechanisms of lipotoxicity in the cardiovascular system.Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart functionHypoxia-inducible factor 1-α induces miR-210 in normoxic differentiating myoblasts.Involvement of MicroRNA-210 Demethylation in Steroid-associated Osteonecrosis of the Femoral HeadElevation of Circulating miR-210-3p in High-Altitude Hypoxic Environment.Diabetic cardiomyopathy and metabolic remodeling of the heart.Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy.Long noncoding RNA dysregulation in ischemic heart failure.RNA Regulation of Lipotoxicity and Metabolic Stress.Epigenetic regulation in heart failure.MicroRNAs: potential mediators and biomarkers of diabetic complications.Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism.Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.
P2860
Q26771750-622084E6-0004-4D4A-B05C-93F31AD11292Q26775037-087EA3C9-3A3C-4F4A-8CE9-6F63CED7F780Q26778539-F813EDF2-1B5F-4693-AE31-9BF9145DF8F5Q26827627-14F90138-8F47-48B5-8B8B-9E8DF6CC5238Q26830607-C3F8586A-2142-497D-98E7-8D68A9D4C5C0Q28079163-68F3F7A1-33C2-4839-87C1-B0433D653AB9Q28081466-25D4F52F-8BB5-4D2C-9A26-5193BBDDFF7CQ28236866-B5C4F1B3-CAE5-46F7-AA4D-3E5647E0BD8FQ28293366-80B13E7D-AACA-4960-BDF3-25CBF9C07064Q28393390-A1C913BE-93F2-4520-AA12-9B1CD4D84963Q28509253-FFE1D90F-0661-45A8-8351-491954DED650Q28536498-2C997086-C228-44BA-9861-FBCF9270A9C3Q28583018-A79E222B-635C-412E-865F-F7C1F939F37FQ28727681-E01BEB0D-F7DD-4945-B284-570D406C0445Q30975559-2E76906C-5020-4FFF-84CF-A8C82BB4ACCFQ33690717-8EBA47F6-3E44-4418-8D44-A5CC2A9F3B81Q34082010-4710DF4A-5AEA-4161-9184-F4DC1BA43C97Q34612138-75CD64C2-B6DC-4041-8DE9-430971661A67Q34980484-61FC6FB4-E875-45B4-8B35-084BC5AC16C8Q35108974-7AAB59B5-4DF5-40CE-AEF8-07C8C77D4BE0Q35109014-AFAF3F89-4B79-4AE6-8942-5478DB2E865EQ35218961-747D7260-D88C-4E6E-BFF8-9C7F42389AEDQ35891149-09D7E675-52A1-400D-B515-F1903C0130CBQ35905574-000D384C-45D2-4FE9-919C-C9653BA4CE2BQ36003227-055A1A85-C1E6-494D-8AA7-790824B767AFQ36094855-C9EBA267-D0D4-4B03-A518-580889AEB95EQ36135052-A2717833-BE2B-4409-BF6B-633C2828331AQ36377252-D7154DA2-749B-451C-9FE1-FD8A6F5DB99BQ36378477-8EB0F970-6B72-4357-8573-AE92E345FF41Q36492926-4F2CAB1C-51F8-417D-A75D-24C760D599B5Q36500699-2EA44716-5C55-4164-BFC4-D4F6F144E264Q36661001-59BEFBA1-06E2-482F-9B51-C062AB5DD8C9Q36672871-C76CF728-87DD-43EB-A540-61D61A0FA472Q36953423-6DD64C26-3C1F-4DA7-A698-489564F29E3AQ37017986-52D38446-968B-4B8C-A97B-071E2FF5F2B4Q37025632-16D43E11-314A-4C1C-B9C2-B4EF2BA5171FQ37114038-7E98826E-6E6F-478A-9F02-792ABD80EE3FQ37146727-8C3D1ED3-BC22-4D51-A166-38AB23052AB2Q37468729-A4E074E8-1BEE-4D91-9C80-6B41CDECF419Q37685243-DA4BB095-3BF9-4E21-BE68-56973284A9A8
P2860
MicroRNA dysregulation in diabetic ischemic heart failure patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA dysregulation in diabetic ischemic heart failure patients
@ast
MicroRNA dysregulation in diabetic ischemic heart failure patients
@en
MicroRNA dysregulation in diabetic ischemic heart failure patients
@nl
type
label
MicroRNA dysregulation in diabetic ischemic heart failure patients
@ast
MicroRNA dysregulation in diabetic ischemic heart failure patients
@en
MicroRNA dysregulation in diabetic ischemic heart failure patients
@nl
prefLabel
MicroRNA dysregulation in diabetic ischemic heart failure patients
@ast
MicroRNA dysregulation in diabetic ischemic heart failure patients
@en
MicroRNA dysregulation in diabetic ischemic heart failure patients
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
MicroRNA dysregulation in diabetic ischemic heart failure patients
@en
P2093
Alexis Malavazos
Diego Arcelli
Marisa Di Donato
Maurizio C Capogrossi
Pasquale Fasanaro
P2860
P304
P3181
P356
10.2337/DB11-0952
P407
P577
2012-03-16T00:00:00Z